FIELD: medicine. SUBSTANCE: composition for connection bioplastic materials contains fibrin glue, Ε-aminocapric acid, trasilole, lysozyme and carbencilline within definite ranges. EFFECT: improves efficiency of the method. 5 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING AUTOLOGOUS FIBRIN WITH CONTROLLED FIBRINOGEN CONTENT WITHOUT USING EXOGENOUS THROMBIN | 2020 |
|
RU2758260C1 |
HEMOSTATIC SPONGE AND METHOD OF ITS PRODUCTION | 2016 |
|
RU2628809C1 |
HAEMOSTATIC SPONGE AND METHOD FOR ITS PREPARATION | 2016 |
|
RU2618896C1 |
TEXTILE MATERIAL FOR HAEMOSTASIS AND METHOD FOR MAKING THEREOF | 2007 |
|
RU2380117C2 |
METHOD FOR OBTAINING COMBINED BIOMATERIAL OF ANTIFUSION EFFECT | 2003 |
|
RU2224549C1 |
METHOD FOR IN VITRO PRODUCTION OF A PERSONALIZED CELL-POPULATED VASCULAR PROSTHESIS | 2021 |
|
RU2764051C1 |
METHOD FOR PRODUCING EX VIVO SOLUBLE FIBRINOGEN | 2014 |
|
RU2571288C1 |
METHOD OF PREPARING POWDERLIKE BIOMATERIAL FOR ENDOSCOPIC COVERAGE OF WOUND SURFACES | 2003 |
|
RU2243777C1 |
RECOMBINANT PLASMID DNA pET15/N-Dest+ AND METHOD FOR THE PREPARATION, THE STRAIN OF ESCHERICHIA COLI BL21(DE3)GOLD, TRANSFORMED BY RECOMBINANT DNA pET15/N-Dest+, AND A METHOD OF ITS RECEPTION, A METHOD FOR OBTAINING RECOMBINANT BIFUNCTION ENZYME - DESTABILASE OF MEDICAL LEECH | 2015 |
|
RU2658429C2 |
METHOD FOR DETERMINING FIBRINOGEN DURING RECALCIFICATION OF CITRATE PLASMA AND EVALUATING ITS FUNCTIONALITY | 2019 |
|
RU2703541C1 |
Authors
Dates
1995-03-10—Published
1989-07-13—Filed